New Insights into the Acetylcholinesterase Inhibitory Activity of Lycopodium clavatum

Abstract

Looking for acetylcholinesterase (AChE) inhibiting compounds within the plant kingdom, we came across the triterpene α-onocerin, which has recently been described as the active principle (IC₅₀ of 5.2 μM) of Lycopodium clavatum L. In order to discover related terpenoid structures with similar AChE inhibitory activity, we investigated the roots of Ononis spinosa L. using Ellman’s reagent in a microplate assay. No inhibitory effect could be measured, not even with the isolated α-onocerin (1), which is in contrast to previous findings. Bioassay-guided fractionation of L. clavatum resulted in the isolation of lyclavatol (2), showing a weak, but dose-dependent inhibitory effect on AChE. ¹H- and ¹³C NMR shift assignments for 1 and 2 are presented and discussed.

Key words

Activity-guided fractionation - acetylcholinesterase - Lycopodium clavatum - triterpenoids - lyclavatol - α-onocerin

References

• 1 Bartus R T, Dean R L, Beer B, Lipps A S. The cholinergic hypothesis of geriatric memory dysfunction: a critical review.  Science. 1982;  217 408-17
• 2 Benzi G, Moretti A. Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer’s disease?.  Eur J Pharmacol. 1998;  346 1-13
• 3 Inestrosa N C, Alvarez A, Perez C A, Moreno R D, Vicente M, Linker C. et al . Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme.  Neuron. 1996;  16 881-91
• 4 Rollinger J M, Hornick A, Langer T, Stuppner H, Prast H. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products.  J Med Chem. 2004;  47 6248-54
• 5 Orhan I, Terzioglu S, Sener B. α-Onocerin: an acetylcholinesterase inhibitor from Lycopodium clavatum .  Planta Med. 2003;  69 265-7
• 6 Rowan M G, Dean P DG. Alpha-onocerin and sterol content of twelve species of Ononis .  Phytochemistry. 1972;  11 3263-5
• 7 European Pharmacopoeia. 4th edn Wien; Verlag Österreich GmbH 2002: p 2009
• 8 Choudhary M I, Shahnaz S, Parveen S, Khalid A, Ayatollahi S AM, Atta-Ur-Rahman . et al . New triterpenoid alkaloid cholinesterase inhibitors from Buxus hyrcana .  J Nat Prod. 2003;  66 739-42
• 9 Atta-Ur- R ahman, Parveen S, Khalid A, Farooq A, Choudhary M I. Acetyl- and butyrylcholinesterase-inhibiting triterpenoid alkaloids from Buxus papillosa .  Phytochemistry. 2001;  58 963-8
• 10 Chung Y K, Heo H J, Kim E K, Kim H K, Huh T L, Lim Y. et al . Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase.  Mol Cells. 2001;  11 137-43
• 11 Ellman G L, Courtney D, Andres V, Featherstone R M. A new and rapid calorimetric determination of acetylcholinesterase activity.  Biochem Pharmacol. 1961;  7 88-95
• 12 Ingkaninan K, de Best C M, van der Heijden R, Hofte A JP, Karabatak B, Irth H. et al . High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products.  J Chromatogr A. 2000;  872 61-73
• 13 Wagner H, Bladt S. Plant Drug Analysis: A Thin Layer Chromatography Atlas. 2nd edn Berlin, Heidelberg; Springer Verlag 1996: pp 338-9
• 14 Pauli G F. Comprehensive spectroscopic investigation of α-onocerin.  Planta Med. 2000;  66 299-302
• 15 Tang X C, Han Y F. Pharmacological profile of huperzine A, a novel acetylcholinesterase inhibitor from Chinese herb.  CNS Drug Rev. 1999;  5 281-300
• 16 Sano T, Fujimoto T, Tsuda Y. Clavatol: a novel triterpenoid of the bisnoronocerane type isolated from Lycopodium clavatum . Chem Commun 1970: 1274-5
• 17 Sano T, Fujimoto T, Tsuda Y. Triterpenoid chemistry. XIII. Lycopodium triterpenoid. 9. Structure of lyclavatol, a novel triterpenoid of the bisnoronocerane type.  Chem Pharm Bull. 1975;  23 1784-8
• 18 Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro .  Method Find Exp Clin. 2000;  22 609-13